Table 4.
Management of acute chest syndrome episodes
| Study variables | Total population (n=91), n (%) |
|---|---|
| Crystalloid fluid | 91 (100) |
| Morphine | 2 (2.2) |
| Paracetamol | 75 (82.4) |
| NSAIDs | 36 (39.6) |
| Antibiotics | 91 (100) |
| Macrolides | 79 (86.8) |
| Third generation cephalosporin | 70 (76.9) |
| Second generation cephalosporin | 21 (23.1) |
| Vancomycin | 43 (47.3) |
| Meropenem | 8 (8.8) |
| Cloxacillin | 4 (4.4) |
| Piperacillin/tazobactam | 1 (1.1) |
| Cefixime | 1 (1.1) |
| Gentamicin | 1 (1.1) |
| Change in antibiotic during hospitalization course | 18 (19.8) |
| Bronchodilators | 77 (84.6) |
| Blood transfusion | |
| Transfusion | 73 (80.2) |
| Type of transfusion* | |
| Simple | 67 (91.8) |
| Exchange | 1 (1.4) |
| Both | 1 (1.4) |
*Missing details were excluded. NSAIDs=Nonsteroidal anti-inflammatory drugs